YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and ...
Guillain-Barré Syndrome, or GBS, is a rare neurological condition. The body's immune system mistakenly attacks its own nerves ...
YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the ...
A warning has been issued over 188 medical conditions which could affect your ability to drive. Failing to report certain medical conditions to the DVLA could result in a fine of up to 1,000. The DVLA ...
Facial paralysis, affecting one or both sides of the face, stems from facial nerve damage, causing weakness and movement loss ...
KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...
The glitz and glam of Hollywood captures the attention of Americans starting from an early age. Beyond celebrities' Instagram Stories and red carpet poses, there are actors out there paying their dues ...
The role of the neurologist is to consider the differential diagnosis, direct investigation according to the clinical syndrome and guide management ... often described as Guillain-Barré-like, are most ...
Short report: Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback